180 results on '"Colak, Yasar"'
Search Results
2. Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target
3. Early Detection of Hepatocellular Carcinoma Recurrence in the Posttransplant Population: A Comparison of RETREAT and Cleveland Clinic Florida Scoring System
4. Assessment of the rs2645424 C/T single nucleotide polymorphisms in the FDFT1 gene, hepatic expression, and serum concentration of the FDFT in patients with nonalcoholic fatty liver disease
5. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication
6. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease
7. The effect of HLA-DQB1 alleles on virologic breakthroughs during chronic hepatitis B treatment with genetically low barrier drugs
8. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women
9. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease
10. Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis
11. Schlomo Dov Goitein’s “Political” Symbiosis in the Secrets of Simon Ben Yohai: A Qur’anic Reappraisal for a Jewish Apocalyptic Source on the Reflecting of an Early Islamic Background.
12. Potential clinical complications of OriseTM gel use, a new submucosal lifting agent: experience from a tertiary care center and review of the literature
13. HLA DQB1 alleles are related with nonalcoholic fatty liver disease
14. S229 OriseTM Gel, A New Submucosal Lifting Agent: Potential Clinical Complications of Its Use: A Case Series
15. Assessment of endothelial function in patients with nonalcoholic fatty liver disease
16. Mean platelet volume in patients with non-alcoholic fatty liver disease: is mean platelet volume ready as a surrogate marker?
17. Potential clinical complications of OriseTM gel use, a new submucosal lifting agent: experience from a tertiary care center and review of the literature.
18. Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
19. Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back
20. The Effect of HLADQB1 Alleles on Breakthrough Events During Chronic HBV Treatment with Genetically Low Barrier Drugs: 1855
21. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome
22. S1106 Early Detection of Hepatocellular Carcinoma Recurrence in the Post-Transplant Population: A Comparison of RETREAT and Cleveland Clinic Florida Scoring System
23. Risk Factors Associated With Postendoscopic Mucosal Resection Bleeding in Patients With Cirrhosis
24. Utility and safety of balloon-assisted enteroscopy in patients with left ventricular assist devices: a retrospective multicenter study
25. Tu1578 UTILITY AND SAFETY OF BALLOON-ASSISTED ENTEROSCOPY IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES: A RETROSPECTIVE MULTICENTER STUDY
26. Mo1769 RISK FACTORS ASSOCIATED WITH POST-ENDOSCOPIC MUCOSAL RESECTION BLEEDING IN PATIENTS WITH CIRRHOSIS: A RETROSPECTIVE MULTICENTER COHORT STUDY
27. Su1498 PERCENTAGE OF CYST GROWTH RATE AS A PREDICTOR FOR MALIGNANCY IN INTRADUCTAL MUCINOUS PAPILLARY NEOPLASMS
28. Risk Factors Associated With Postendoscopic Mucosal Resection Bleeding in Patients With Cirrhosis: A Retrospective Multicenter Cohort Study.
29. Chapter 1 - A Disease Entity Is Identified
30. Risk Factors Associated With Postendoscopic Mucosal Resection Bleeding in Patients With Cirrhosis
31. Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease
32. Gastric carcinoid tumor after laparoscopic sleeve gastrectomy
33. Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C
34. A Potential Treatment of Non-Alcoholic Fatty Liver Disease with SIRT1 Activators
35. Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
36. TLR4 Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Controls
37. Impaired left ventricular mechanics in nonalcoholic fatty liver disease
38. Melanoma metastasis to the breast: A diagnostic pitfall
39. Colonic duplication in adulthood presenting with diarrhea
40. Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: a 2D speckle tracking imaging study
41. Tu2043 Is the TLR-4 Gene Polymorphism Play a Protective Role in the Development of NAFLD in Humans ?
42. Association between toll-like receptor 4 polymorphism and type 2 diabetes mellitus
43. Prognostic Significance of DR-70 Levels in Dysplastic Colorectal Polyps
44. Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease
45. Assessment of endothelial function in patients with nonalcoholic fatty liver disease
46. Nonalcoholic Fatty Liver Disease: A Nutritional Approach
47. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease
48. Sa1242 Serum Anti-MüLlerian Hormone Levels are Lower in Reproductive-Age Women With Crohn's Disease Compared to Healthy Control Women
49. Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease
50. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.